Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain

INTRODUCTION: This study aimed to describe utilization patterns, persistence, resource utilization and costs in patients with type 2 diabetes mellitus initiating treatment with glucagon-like peptide 1 receptor agonists in routine clinical practice in Spain. METHODS: This retrospective study of medic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Norrbacka, Kirsi, Sicras-Mainar, Antoni, Lebrec, Jeremie, Artime, Esther, Díaz, Silvia, Tofé-Povedano, Santiago, Hernández, Ignacio, Romera, Irene
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099971/
https://ncbi.nlm.nih.gov/pubmed/33860927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01039-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars